MAXIPIME FOR INJECTION-PWS IV 2GM DIN 02163640
Status: Cancelled Post Market
Holder: BRISTOL-MYERS SQUIBB CANADA
Molecule: CEFEPIME (CEFEPIME HYDROCHLORIDE)
Health Canada record
| Active ingredient(s) | CEFEPIME (CEFEPIME HYDROCHLORIDE) 2 G |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01DE01 CEFEPIME |
| Original market date | 31-Dec-1995 |
| Current status date | 28-Jan-2015 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bristol-Myers Squibb Canada — licence 100100, currently licensed, last inspection rating C (2026-03-18).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CEFEPIME (CEFEPIME HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02467496 | APO-CEFEPIME | APOTEX INC | Powder For Solution | CEFEPIME (CEFEPIME HYDROCHLORIDE) 1 G | Marketed |
| 02467518 | APO-CEFEPIME | APOTEX INC | Powder For Solution | CEFEPIME (CEFEPIME HYDROCHLORIDE) 2 G | Marketed |
| 02319020 | CEFEPIME FOR INJECTION | APOTEX INC | Powder For Solution | CEFEPIME (CEFEPIME HYDROCHLORIDE) 1 G | Approved |
| 02499096 | CEFEPIME FOR INJECTION USP | HIKMA CANADA LIMITED | Powder For Solution | CEFEPIME (CEFEPIME HYDROCHLORIDE) 2 G | Marketed |
| 02499088 | CEFEPIME FOR INJECTION USP | HIKMA CANADA LIMITED | Powder For Solution | CEFEPIME (CEFEPIME HYDROCHLORIDE) 1 G | Approved |
| 02464004 | CEFEPIME FOR INJECTION, USP | QILU PHARMACEUTICAL CO., LTD. | Powder For Solution | CEFEPIME (CEFEPIME HYDROCHLORIDE) 2 G | Approved |
| 02463997 | CEFEPIME FOR INJECTION, USP | QILU PHARMACEUTICAL CO., LTD. | Powder For Solution | CEFEPIME (CEFEPIME HYDROCHLORIDE) 1 G | Approved |
| 02319039 | CEFEPIME FOR INJECTION | APOTEX INC | Powder For Solution | CEFEPIME (CEFEPIME HYDROCHLORIDE) 2 G | Dormant |
| 02163632 | MAXIPIME FOR INJECTION -PWS IV IM 1G | BRISTOL-MYERS SQUIBB CANADA | Powder For Solution | CEFEPIME (CEFEPIME HYDROCHLORIDE) 1 G | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 4959 | 1995-06-02 | New Drug Submission (NDS) |